News

COPAN Streamlines Production to Yield Maximum Output of Viral Transport Kits for Collection of Upper Respiratory Samples, Including COVID-19

February 28, 2020

Brescia, Italy February 28, 2020 – With the surging demand for sample collection kits for diagnosing COVID-19 and other upper respiratory tract pathogens, COPAN is concentrating its efforts on strategic items to maximize product output and supply during the ongoing…

Read More

CDC Recommends Nasopharyngeal Swabs AND Oropharyngeal Swabs as Suitable for Upper Respiratory Tract Specimens for Investigations of Novel Coronavirus (2019-nCoV)

January 31, 2020

On January 30th, 2020, the World Health Organization (WHO) held its second meeting in Geneva of the International Health Regulations Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). During the meeting the committee agreed that the outbreak constitutes a…

Read More

Versatile Easy-To-Use FecalSwab® is an Excellent Alternative to Traditional Containers for Accurate and Timely Detection of Gastrointestinal Pathogens from Fecal or Rectal Specimens

December 17, 2019

Fecal specimens have been utilized in the microbiology laboratory for years in order to detect bacterial gastrointestinal (GI) pathogens by culture.  More recently, molecular assays have been developed to detect not only bacterial GI pathogens, but viral and parasitic causes…

Read More
Norman Sharples Presenting PhenoMATRIX

COPAN Continues to Make Great Strides in Advancing Artificial Intelligence (A.I.) and Digital Plate Reading for Microbiology

October 22, 2019

COPAN continues to innovate and is leading the field of Artificial Intelligence (A.I.) and digital culture plate reading in clinical Microbiology. A groundbreaking study titled “Automated Detection of Streptococcus pyogenes pharyngitis using COLOREX Strep A CHROMagar and WASPLab™ Artificial Intelligence Chromogenic Detection Module Software” was recently published on the Journal of Clinical Microbiology (JCM). The study is the first-in-its class peer-reviewed publication on PhenoMATRIX™ used with COLOREX Strep A culture media for the automatic detection of Group A Strep (GAS).

Read More

COPAN and Alverno Laboratories Partner to Successfully Validate PhenoMATRIX™ for Detection of Group A Streptococcus Using CHROMagar’s COLOREX™ Media

June 14, 2019

COPAN and Alverno Laboratories Partner to Successfully Validate PhenoMATRIX™ for Detection of Group A Streptococcus Using CHROMagar’s COLOREX™ Media

Read More

COPAN Announces FecalSwab® Stool Collection and Transport Device Certified Free of Nucleic Acids

March 28, 2019

COPAN Announces FecalSwab® Stool Collection and Transport Device Certified Free of Nucleic Acids

Read More

COPAN Maintains its Global Commitment to Address Unauthorized Use of its Patented Technology

January 16, 2019

COPAN is focused on the industry standard quality of its innovative products and remains actively committed to protecting its intellectual property rights globally, including the patent infringement and unfair competition lawsuit that COPAN filed in U.S. federal district court last year.

Read More

Summary Judgment in favor of COPAN against Puritan Medical Products’ Claim for Bad Faith Assertion of Patent Infringement

September 10, 2018

Maine’s highest court, the Maine Supreme Judicial Court, affirmed a summary judgment entered in favor of Copan Italia S.p.A. and against Puritan Medical Products Company, LLC on Puritan’s state law claim for bad faith assertion of patent infringement.

Read More

COPAN Announces the Worldwide Launch of CYCLONE AUTO-PREP™ with Smart Incubators and AI for Automatic Determination of Bacterial Growth During the Upcoming International Association for Food Protection (IAFP) Annual Meeting

July 3, 2018

COPAN Announces the Worldwide Launch of CYCLONE AUTO-PREP™ with Smart Incubators and AI for Automatic Determination of Bacterial Growth During the Upcoming International Association for Food Protection (IAFP) Annual Meeting

Read More

COPAN Announces Lawsuit for Patent Infringement and Unfair Competition Against Puritan Medical Products Co., LLC and Puritan Diagnostics LLC

June 4, 2018

COPAN Italia S.p.A. and its U.S. subsidiary, COPAN Diagnostics Inc. announced today that they have filed a lawsuit against Puritan Medical Products Co., LLC and Puritan Diagnostics LLC, in the United States District Court for the District of Maine for infringement of U.S. Patent No. 8,114,027, U.S. Patent No. 8,317,728, U.S. Patent No. 8,979,784, U.S. Patent No. 9,011,358, and U.S. Patent No. 9,173,779.

Read More